Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from OptumRX

Stocks Settle Higher on Q1 Earnings Optimism

The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.87%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.67%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.02%. US stock indexes settled moderately higher on Monday, with the Dow Jones Industrials posting...

Stocks Soar with Earnings on Tap

Stocks Soar with Earnings on Tap

The S&P 500 Index ($SPX ) (SPY ) is up +1.33%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +1.12%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.53%. US stock indexes today are surging higher. Reduced geopolitical tensions are positive for stocks after...

Stocks Mixed with Earnings on Tap

Stocks Mixed with Earnings on Tap

The S&P 500 Index ($SPX ) (SPY ) this morning is up +0.16%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.04%. US stock indexes today are mixed. Reduced geopolitical tensions are positive for stocks...

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Stocks Push Higher Ahead of Megacap Tech Earnings

The S&P 500 Index ($SPX ) (SPY ) this morning is up +0.42%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.32%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.57%. US stock indexes are moderately higher today as geopolitical tensions ease from the...

This Essential Medical Treatment Could Finally Become Affordable For Everyone

Pharmaceutical giant Eli Lilly is slashing the list prices for some of its most popular insulin products by 70 percent.

Eli Lilly is cutting insulin prices and capping copays at $35 – 5 questions answered

Pharmaceutical giant Eli Lilly is slashing the list prices for some of its most popular insulin products by 70% and capping insulin copays at US$35 for uninsured patients and those with private health insurance. These changes follow efforts by the federal government, the California state government, nonprofits and some companies…

The Conversation

Drug company middlemen likely to be a focus in 118th Congress

WASHINGTON — Factions of the health care system and members of Congress are turning their fire on an oft-maligned part of the drug pricing system — the middlemen who negotiate discounts with drug companies on behalf of health plans.

Tribune News Service

inkl

Read news from The Economist, FT, and more,
with one subscription

Drug company middlemen likely to be a focus in 118th Congress - Roll Call

Drug company middlemen likely to be a focus in 118th Congress - Roll Call

PBMs argue that the rebates they collect from drug companies in exchange for coverage by a health plan are used to lower premiums.

Drugmakers sued over insulin prices

Drugmakers sued over insulin prices

California's Attorney General Rob Bonta sued the six major companies that dominate the U.S. insulin market

Want free, at-home COVID-19 tests from pharmacies and insurers? It’s not always easy, despite requirements

CHICAGO -- Some Illinois residents say they’re still having trouble getting free at-home COVID-19 tests from pharmacies and insurance companies, more than three months after the White House began requiring insurers to cover them.

Chicago Tribune

1

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

the Wall Street Journal

UnitedHealth Group

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

237,007 stories

Washington D.C.

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play